Armuzzi, Alessandro <br/><br/>
Long-term combination therapy with infliximab plus azathioprine predicts sustained steroid-free clinical benefit in steroid-dependent ulcerative colitis.  [electronic resource] 

 -  Inflammatory bowel diseases  Aug 2014 
 - 1368-74 p.  digital 
<br/><br/> Publication Type: Journal Article; Observational Study 
<br/><br/><label>ISSN: </label>1536-4844 
<br/><br/><label>Standard No.: </label>10.1097/MIB.0000000000000115  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antibodies, Monoclonal--therapeutic use<br/>Azathioprine--therapeutic use<br/>Colitis, Ulcerative--drug therapy<br/>Drug Therapy, Combination<br/>Female<br/>Follow-Up Studies<br/>Gastrointestinal Agents--therapeutic use<br/>Humans<br/>Immunosuppressive Agents--therapeutic use<br/>Infliximab<br/>Male<br/>Middle Aged<br/>Prognosis<br/>Prospective Studies<br/>Remission Induction<br/>Retrospective Studies<br/>Steroids--administration & dosage<br/>Survival Rate